TRAVERE THERAPEUTICS INC NOTE 0.500% 5/1
TRAVERE THERAPEUTICS INC NOTE 0.500% 5/1 is a security (CUSIP 89422GAB3) tracked across SEC portfolio filings. 6 institutional managers reported $118.7M on Form 13F as of 2026-06-30; 1 registered fund positions totaling $191K via N-PORT as of 2026-05-29.
Summary
- Issuer: TRAVERE THERAPEUTICS INC
- Class: NOTE 0.500% 5/1
- CUSIP: 89422GAB3
- Asset category: DBT
- 13F holders: 6
- 13F value: $118.7M
- 13F period: 2026-06-30
- N-PORT fund positions: 1
- N-PORT value: $191K
- N-PORT report: 2026-05-29
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| Context Capital Management, LLC | LAJOLLA, CA | $59.5M | 50,500,000 |
| Calamos Advisors LLC | NAPERVILLE, IL | $57.6M | 48,813,000 |
| RWC Asset Management LLP | LONDON, X0 | $1.5M | 1,281,000 |
| Calamos Wealth Management LLC | NAPERVILLE, IL | $121K | 103,000 |
| CHOREO, LLC | ROCKFORD, IL | $15K | 13,000 |
| FIFTH THIRD BANCORP | CINCINNATI, OH | $11K | 9,000 |
Top fund holders (N-PORT)
More